Cargando…
Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity
BACKGROUND: Diabetes mellitus (DM) is a common concomitant disease of late-onset myasthenia gravis (MG). However, the impacts of DM on the progression of late-onset MG were unclear. METHODS: In this study, we examined the immune response in experimental autoimmune myasthenia gravis (EAMG) rats with...
Autores principales: | Zhang, Peng, Yang, Chun-Lin, Du, Tong, Liu, Yu-Dong, Ge, Meng-Ru, Li, Heng, Liu, Ru-Tao, Wang, Cong-Cong, Dou, Ying-Chun, Duan, Rui-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549151/ https://www.ncbi.nlm.nih.gov/pubmed/34702288 http://dx.doi.org/10.1186/s12974-021-02298-6 |
Ejemplares similares
-
Correction to: Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity
por: Zhang, Peng, et al.
Publicado: (2021) -
Exosomes derived from statin-modified bone marrow dendritic cells increase thymus-derived natural regulatory T cells in experimental autoimmune myasthenia gravis
por: Zhang, Peng, et al.
Publicado: (2019) -
CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells
por: Yang, Chun-Lin, et al.
Publicado: (2019) -
Circulating CXCR5
(+) natural killer cells are expanded in patients with myasthenia gravis
por: Ge, Meng‐Ru, et al.
Publicado: (2023) -
Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway
por: Wang, Cong-Cong, et al.
Publicado: (2015)